Sign In
Buy DGX
$193.67
+0.510 (+0.264%)
At Close: Jun 03, 2026
Anthem and Quest Diagnostics Form Strategic Relationship
10:45am, Monday, 17'th Aug 2020
Anthem Inc. (NYSE: ANTM) and Quest Diagnostics (NYSE: DGX) have entered into a strategic relationship by collaborating on a variety of outcomes-based programs designed to create an improved health car
Quest Diagnostics Releases Annual Environmental, Social & Governance Report
08:45pm, Wednesday, 12'th Aug 2020
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, today released its Annual Environmental, Social & Governance Report for 2019.
Global Food Allergen Testing Market 2020-2024: Breakdown by LC/MS, Immunoassay/ELISA, and PCR Technology - ResearchAndMarkets.com
12:00am, Tuesday, 11'th Aug 2020
The
Ariel Investments' John Rogers Shares Insight About Stocks, Racial Relations
12:00pm, Monday, 10'th Aug 2020
John Rogers, the first Black founder of a mutual fund complex, offers advice about investments and what this summer of agitation is telling Americans.
Quest Diagnostics: A Steady Investment Opportunity Buoyed By Current Market Tailwinds (NYSE:DGX)
09:55am, Monday, 10'th Aug 2020
Quest Diagnostics operates the world's largest clinical testing data-store and provides diagnostic services across the entire healthcare spectrum.
Oxford Immunotec Global PLC (OXFD) CEO Peter Wrighton-Smith on Q2 2020 Results - Earnings Call Transcript
01:44pm, Sunday, 09'th Aug 2020
Oxford Immunotec Global PLC (NASDAQ:OXFD) Q1 2021 Earnings Conference Call August 04, 2020 08:00 AM ET Company Participants Matt McLaughlin - Chief Financial Officer Peter Wrighton-Smith - Chief Execu
Becton Dickinson Earnings Top, But BDX Stock Falls On Weak Sales
08:21pm, Thursday, 06'th Aug 2020
Becton Dickinson earnings beat views, but the coronavirus test maker missed on revenue and gave weak full-year guidance below expectations. Shares tumbled out of a buy zone early Thursday,
$1.6 Billion Worldwide Specimen Validity Testing Industry to 2027 - Impact of COVID-19 on the Market - ResearchAndMarkets.com
12:00am, Thursday, 06'th Aug 2020
The
Pale Blue Portfolio Review, May 18-July 31: 17 Buys, 2 Sells, 15.45% Gains
10:41pm, Tuesday, 04'th Aug 2020
The Pale Blue Portfolio gained 15.45% between May 18 and July 31. I slightly adjusted my purchasing strategy in July.
Oxford Immunotec Global PLC (OXFD) Q2 2020 Earnings Call Transcript
10:00pm, Tuesday, 04'th Aug 2020
It is now my pleasure to turn the call over to Matt McLaughlin, Chief Financial Officer. Good morning and thank you for joining us to review Oxford Immunotec's financial results for the second quarte
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has completed its previously announced acquisition of its joint venture partners
Quest Diagnostics Launches Automated Next Generation Sequencing (NGS) Engine To Power AncestryHealth®
12:30pm, Monday, 03'rd Aug 2020
A new innovation in advanced genetic sequencing automation from Quest Diagnostics (NYSE: DGX) will now enable individuals to access highly accurate genetic testing providing insights into inherited di
Janney Montgomery Scott LLC Lowers Stock Holdings in Quest Diagnostics Inc (NYSE:DGX)
07:16am, Monday, 03'rd Aug 2020
Janney Montgomery Scott LLC decreased its position in shares of Quest Diagnostics Inc (NYSE:DGX) by 31.3% during the second quarter, HoldingsChannel reports. The firm owned 13,666 shares of the medica
Ancestry® Launches AncestryHealth® Powered by Next Generation Sequencing (NGS)
12:00am, Monday, 03'rd Aug 2020
Ancestry®, the global leader in family history and consumer genomics, today announced the launch of AncestryHealth® powered by Next Generation Sequenc
Covid-19 testing delays create a public health nightmare as schools and workplaces try to reopen
03:00pm, Sunday, 02'nd Aug 2020
Across the country, patients are reporting delays in getting their Covid-19 test results because of major supply shortages.
